⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELTX News
Elicio Therapeutics, Inc. Common Stock
Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine
globenewswire.com
ELTX
Nsight Health Founder and CEO Michael Ciullo Named to Becker's Hospital Review's "Rising Stars: 188 Healthcare Leaders Under 40 | 2026"
prnewswire.com
ELTX
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
globenewswire.com
ELTX
Form 8-K
sec.gov
ELTX
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPĪ³-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
globenewswire.com
ELTX
Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer
globenewswire.com
ELTX
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
ELTX
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
ELTX
Form 8-K
sec.gov
ELTX
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
ELTX